Genscript Biotech Corporation
GNNSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $132 | $1,446 | $1,024 | $1,181 |
| Short-Term Investments | $489 | $482 | $439 | $222 |
| Receivables | $119 | $300 | $172 | $169 |
| Inventory | $31 | $53 | $60 | $44 |
| Other Curr. Assets | $64 | $72 | $70 | $21 |
| Total Curr. Assets | $835 | $2,353 | $1,765 | $1,638 |
| Property Plant & Equip (Net) | $603 | $751 | $647 | $492 |
| Goodwill | $1 | $1 | $3 | $14 |
| Intangibles | $13 | $19 | $24 | $52 |
| Long-Term Investments | $3,301 | $91 | -$423 | -$204 |
| Tax Assets | $28 | $16 | $15 | $5 |
| Other NC Assets | $498 | $156 | $516 | $235 |
| Total NC Assets | $4,443 | $1,034 | $781 | $595 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $5,278 | $3,387 | $2,546 | $2,233 |
| Liabilities | – | – | – | – |
| Payables | $30 | $40 | $56 | $30 |
| Short-Term Debt | $96 | $66 | $45 | $8 |
| Tax Payable | $15 | $18 | $22 | $16 |
| Deferred Revenue | $0 | $92 | $42 | $35 |
| Other Curr. Liab. | $166 | $279 | $382 | $376 |
| Total Curr. Liab. | $307 | $495 | $546 | $464 |
| LT Debt | $74 | $351 | $305 | $148 |
| Deferred Rev, NC | $0 | $48 | $18 | $16 |
| Deferred Tax Liab, NC | $6 | $6 | $8 | $8 |
| Other NC Liab. | $567 | $443 | $307 | $261 |
| Total NC Liab. | $648 | $848 | $638 | $433 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $65 | $73 | $55 | $35 |
| Total Liabilities | $955 | $1,343 | $1,184 | $1,140 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $1,937 | $0 | $215 |
| Common Stock | $2 | $2 | $2 | $2 |
| Retained Earnings | $2,350 | -$632 | -$502 | -$558 |
| AOCI | -$21 | $57 | $50 | $61 |
| Other Equity | $1,975 | $1,929 | $1,461 | $1,333 |
| Total Equity | $4,321 | $1,391 | $1,011 | $1,046 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $2 | $653 | $352 | $213 |
| Total Liab. & Tot. Equity | $5,278 | $3,387 | $2,546 | $2,233 |
| Net Debt | $39 | -$1,029 | -$674 | -$1,025 |